Browse services by
Browse by Model Type
Browse by Tumor Type
Solid Tumors
Hematologic Malignancies
Browse by Modality/Target
Targets
Browse by Application
Analytical Assays
NEW CAPABILITY
In-house SPECT/CT imaging
See where your radiopharmaceutical goes and when, with longitudinal SPECT/CT in our own lab.
Data Ecosystem
Resource Library
Company
Investors
CDX
Tumor indication
Kidney
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.
